ROBERT A HOUGHTON
Allopathic & Osteopathic Physicians|Family Medicine SAN DIEGO, CA NPI 1124138045
Browse related groups: Allopathic & Osteopathic Physicians|Family Medicine CA ViiV Healthcare Company All categories
General Payments — all program years on this page
$32,496.99
- Category: General Payments
- Program years: PY2018–2024
- Record count: 1,671
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $4,569.19 across 215 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $4,557.60 | 214 |
| Education | $11.59 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| ViiV Healthcare Company | $1,499.65 | 52 |
| Gilead Sciences, Inc. | $1,398.86 | 84 |
| ABBVIE INC. | $272.74 | 16 |
| Acerta Pharma LLC | $243.98 | 12 |
| EMD Serono, Inc. | $210.61 | 10 |
| Merck Sharp & Dohme Corporation | $123.04 | 6 |
| Amgen Inc. | $98.01 | 4 |
| PFIZER INC. | $92.61 | 4 |
| Exact Sciences Corporation | $88.45 | 3 |
| GlaxoSmithKline, LLC. | $81.90 | 3 |
| Verity Pharmaceuticals Inc. | $77.96 | 3 |
| Antares Pharma, Inc. | $55.80 | 3 |
| Theratechnologies Inc. | $54.71 | 2 |
| TOLMAR, INC. | $43.17 | 3 |
| Hologic Sales and Service, LLC | $42.60 | 1 |
| Napo Pharmaceuticals Inc | $39.34 | 2 |
| Lilly USA, LLC | $26.54 | 1 |
| Seqirus USA Inc | $23.69 | 1 |
| Vanda Pharmaceuticals Inc. | $22.58 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $22.04 | 1 |
| Kowa Pharmaceuticals America, Inc. | $18.31 | 1 |
| IDORSIA PHARMACEUTICALS US INC | $17.23 | 1 |
| Philips Electronics North America Corporation | $15.37 | 1 |
By program year
Records — PY2024 (215)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.